On the evening of April 16, Meinian Health released its 2024 annual report. The company achieved operating income of 10.702 billion yuan and net profit attributable to shareholders of 283 million yuan; the consumption demand for personal health management was upgraded, and the proportion of individual customers accounted for 24.1% of the revenue; the company's physical examination customer unit price was 672 yuan, continuing to maintain a stable increase; the main revenue from combined with AI technology means exceeded 215 million yuan, mainly including cardiopulmonary screening, fundus AI, and other income.

2025 is the first year for Meinian Health to enter a new decade of development stage, and it is also the first year for comprehensively entering the era of digital and intelligent health management. It is the "efficiency year" of business management, the "product year" of innovative products, the "experience year" of continuous optimization of customer service, and the "data year" of deep digging for data-rich mining. Looking ahead to 2025, the company stated that it will comprehensively promote diversified revenue growth, drive the dual-wheel drive of group inspections, and focus on extending services and products for physical examinations. At the same time, it will make full use of the advantages of health big data, take discipline construction and AI drive as the base to continuously create "specialized, specialized and new" products and AI intelligent bodies, and use the advantages of domestic leading C-end traffic entrance platform and application scenarios to continue to deepen the "AI+Health Management", accelerate the construction of a new business format for "two hours of physical examinations, 365 days of service" to promote sustainable growth and high-quality development of operating performance.

[Editor in charge: Sun Hui]